CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Schrödinger, Inc. - SDGR CFD

    27.23
    0.77%
    0.33
    Low: 26.72
    High: 27.37
    Market Trading Hours* (UTC) Opens on Wednesday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.33
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Schrodinger Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 27.44
    Open* 26.98
    1-Year Change* 8.22%
    Day's Range* 26.72 - 27.37
    52 wk Range 15.85-59.24
    Average Volume (10 days) 630.76K
    Average Volume (3 months) 30.08M
    Market Cap 2.50B
    P/E Ratio 40.26
    Shares Outstanding 81.04M
    Revenue 193.79M
    EPS 0.86
    Dividend (Yield %) N/A
    Beta 1.29
    Next Earnings Date Nov 1, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Oct 2, 2023 27.44 -0.44 -1.58% 27.88 28.16 27.07
    Sep 29, 2023 28.22 0.32 1.15% 27.90 28.37 27.50
    Sep 28, 2023 27.28 -0.17 -0.62% 27.45 27.77 27.00
    Sep 27, 2023 27.12 -0.23 -0.84% 27.35 28.02 26.81
    Sep 26, 2023 27.31 -0.51 -1.83% 27.82 28.25 26.87
    Sep 25, 2023 28.18 -0.20 -0.70% 28.38 28.81 27.79
    Sep 22, 2023 28.96 -0.71 -2.39% 29.67 30.08 28.60
    Sep 21, 2023 29.45 -0.50 -1.67% 29.95 30.23 29.45
    Sep 20, 2023 30.67 -0.48 -1.54% 31.15 31.65 30.54
    Sep 19, 2023 31.10 -0.17 -0.54% 31.27 31.87 30.80
    Sep 18, 2023 31.68 -0.41 -1.28% 32.09 32.22 30.95
    Sep 15, 2023 32.76 -0.25 -0.76% 33.01 33.20 32.28
    Sep 14, 2023 33.13 -0.12 -0.36% 33.25 33.95 32.77
    Sep 13, 2023 33.15 -0.18 -0.54% 33.33 34.33 33.00
    Sep 12, 2023 33.61 0.16 0.48% 33.45 33.99 33.45
    Sep 11, 2023 33.90 -0.19 -0.56% 34.09 34.49 33.68
    Sep 8, 2023 33.83 -0.67 -1.94% 34.50 34.83 33.75
    Sep 7, 2023 34.72 -0.13 -0.37% 34.85 35.10 33.95
    Sep 6, 2023 35.50 -0.10 -0.28% 35.60 36.27 34.97
    Sep 5, 2023 35.69 -0.53 -1.46% 36.22 36.28 34.94

    Schrödinger, Inc. Events

    Time (UTC) Country Event
    Wednesday, November 1, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q3 2023 Schrodinger Inc Earnings Release
    Q3 2023 Schrodinger Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, February 26, 2024

    Time (UTC)

    21:00

    Country

    US

    Event

    Q4 2023 Schrodinger Inc Earnings Release
    Q4 2023 Schrodinger Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 180.955 137.931 108.095 85.543 66.639
    Revenue 180.955 137.931 108.095 85.543 66.639
    Cost of Revenue, Total 79.933 72.311 44.623 36.45 23.702
    Gross Profit 101.022 65.62 63.472 49.093 42.937
    Total Operating Expense 327.772 249.374 169.011 124.258 94.608
    Selling/General/Admin. Expenses, Total 120.954 86.159 59.693 46.291 34.259
    Research & Development 126.372 90.904 64.695 38.786 34.215
    Operating Income -146.817 -111.443 -60.916 -38.715 -27.969
    Interest Income (Expense), Net Non-Operating -2.309 10.635 34.624 12.743 -0.379
    Net Income Before Taxes -149.126 -100.808 -26.292 -25.972 -28.348
    Net Income After Taxes -149.189 -101.219 -26.637 -25.681 -28.425
    Net Income Before Extra. Items -149.186 -100.393 -24.463 -24.571 -28.425
    Total Extraordinary Items
    Net Income -149.186 -100.393 -24.463 -24.571 -28.425
    Income Available to Common Excl. Extra. Items -149.186 -100.393 -24.463 -24.571 -28.425
    Income Available to Common Incl. Extra. Items -149.186 -100.393 -24.463 -24.571 -28.425
    Diluted Net Income -149.186 -100.393 -24.463 -24.571 -28.425
    Diluted Weighted Average Shares 71.1734 70.5949 60.0247 61.4472 61.4472
    Diluted EPS Excluding Extraordinary Items -2.09609 -1.4221 -0.40755 -0.39987 -0.46259
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -2.09609 -1.4221 -0.40755 -0.39987 -0.46259
    Depreciation / Amortization 0.513 2.731 2.432
    Minority Interest 0.003 0.826 2.174 1.11
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 35.189 64.782 56.843 36.98 38.469
    Revenue 35.189 64.782 56.843 36.98 38.469
    Cost of Revenue, Total 21.379 19.089 18.139 19.779 21.335
    Gross Profit 13.81 45.693 38.704 17.201 17.134
    Total Operating Expense 96.322 95.283 85.381 83.143 81.942
    Selling/General/Admin. Expenses, Total 32.238 35.453 32.7 30.479 29.484
    Research & Development 42.705 40.741 34.542 32.885 31.123
    Operating Income -61.133 -30.501 -28.538 -46.163 -43.473
    Interest Income (Expense), Net Non-Operating 40.654 185.996 1.194 6.501 -3.872
    Net Income Before Taxes -16.153 155.495 -27.344 -39.662 -47.653
    Net Income After Taxes 4.278 129.136 -27.208 -39.856 -47.686
    Minority Interest 0.001 0.003
    Net Income Before Extra. Items 4.278 129.136 -27.207 -39.853 -47.686
    Net Income 4.278 129.136 -27.207 -39.853 -47.686
    Income Available to Common Excl. Extra. Items 4.278 129.136 -27.207 -39.853 -47.686
    Income Available to Common Incl. Extra. Items 4.278 129.136 -27.207 -39.853 -47.686
    Diluted Net Income 4.278 129.136 -27.207 -39.853 -47.686
    Diluted Weighted Average Shares 75.0643 73.8186 71.2716 71.208 71.1619
    Diluted EPS Excluding Extraordinary Items 0.05699 1.74937 -0.38174 -0.55967 -0.67011
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.05699 1.74937 -0.38174 -0.55967 -0.67011
    Other, Net 4.326 -0.308
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 533.989 625.06 682.978 118.536 104.69
    Cash and Short Term Investments 451.087 576.479 642.691 85.83 84.067
    Cash & Equivalents 90.474 120.267 202.296 25.986 77.716
    Short Term Investments 360.613 456.212 440.395 59.844 6.351
    Total Receivables, Net 69.09 40.551 35.378 25.738 18.021
    Accounts Receivable - Trade, Net 67.331 40.015 35.012 25.58 17.995
    Prepaid Expenses 8.569 5.03 4.409 6.468 2.602
    Total Assets 688.587 756.487 746.263 155.27 120.73
    Property/Plant/Equipment, Total - Net 120.226 85.409 15.269 19.03 7.967
    Property/Plant/Equipment, Total - Gross 134.339 97.764 29.071 29.592 17.4
    Accumulated Depreciation, Total -14.113 -12.355 -13.802 -10.562 -9.433
    Intangibles, Net 0.587 0 0.015
    Long Term Investments 25.683 43.167 45.664 15.366 5.444
    Other Long Term Assets, Total 3.311 2.851 2.352 2.338 2.614
    Total Current Liabilities 108.799 91.211 73.205 45.02 27.005
    Accounts Payable 9.47 8.079 8.398 3.524 2.773
    Accrued Expenses 41.398 27.764 19.404 16.442 6.587
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 57.931 55.368 45.403 25.054 17.645
    Total Liabilities 240.693 199.416 122.248 57.054 30.603
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 131.883 108.191 49.039 11.993 3.598
    Total Equity 447.894 557.071 624.015 98.216 90.127
    Preferred Stock - Non Redeemable, Net 0 191.58 161.687
    Common Stock 0.714 0.71 0.699 0.061 0.059
    Additional Paid-In Capital 828.7 786.964 752.558 11.655 8.915
    Retained Earnings (Accumulated Deficit) -379.138 -229.952 -129.559 -105.096 -80.525
    Other Equity, Total -2.382 -0.651 0.317 0.016 -0.009
    Total Liabilities & Shareholders’ Equity 688.587 756.487 746.263 155.27 120.73
    Total Common Shares Outstanding 71.3279 70.9987 69.8777 61.4472 61.4472
    Other Current Assets, Total 5.243 3 0.5 0.5
    Minority Interest 0.011 0.014 0.004 0.041
    Goodwill, Net 4.791
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 603.734 533.989 524.201 556.872 586.168
    Cash and Short Term Investments 527.688 451.087 473.556 509.565 525.532
    Cash & Equivalents 233.206 90.474 102.817 127.319 117.257
    Short Term Investments 294.482 360.613 370.739 382.246 408.275
    Total Receivables, Net 60.164 69.09 35.738 31.745 45.594
    Accounts Receivable - Trade, Net 60.272 67.331 34.64 30.782 44.086
    Prepaid Expenses 11.396 8.569 9.104 12.062 11.542
    Other Current Assets, Total 4.486 5.243 5.803 3.5 3.5
    Total Assets 838.773 688.587 661.985 687.88 719.537
    Property/Plant/Equipment, Total - Net 122.475 120.226 102.217 101.657 89.256
    Long Term Investments 101.539 25.683 27.177 21.903 37.002
    Other Long Term Assets, Total 6.234 3.311 2.879 1.804 1.334
    Total Current Liabilities 123.407 108.799 88.821 85.59 85.532
    Accounts Payable 11.987 9.47 10.918 5.263 9.766
    Accrued Expenses 33.524 41.398 33.983 32.887 21.995
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 77.896 57.931 43.92 47.44 53.771
    Total Liabilities 248.513 240.693 198.875 194.822 188.87
    Total Long Term Debt 0 0 0 0 0
    Minority Interest 0.011 0.012 0.015 0.003
    Other Liabilities, Total 125.106 131.883 110.042 109.217 103.335
    Total Equity 590.26 447.894 463.11 493.058 530.667
    Common Stock 0.715 0.714 0.712 0.712 0.712
    Additional Paid-In Capital 840.446 828.7 818.015 807.827 797.004
    Retained Earnings (Accumulated Deficit) -250.002 -379.138 -351.931 -312.078 -264.392
    Other Equity, Total -0.899 -2.382 -3.686 -3.403 -2.657
    Total Liabilities & Shareholders’ Equity 838.773 688.587 661.985 687.88 719.537
    Total Common Shares Outstanding 71.5262 71.3279 71.232 71.1913 71.1366
    Goodwill, Net 4.791 4.791 4.791 4.791 4.791
    Intangibles, Net 0 0.587 0.72 0.853 0.986
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -149.189 -101.219 -26.637 -25.681 -28.425
    Cash From Operating Activities -119.683 -70.669 16.757 -26.059 -23.711
    Cash From Operating Activities 4.344 2.847 3.658 3.64 2.894
    Non-Cash Items 46.537 23.026 -19.44 -8.313 1.539
    Cash Taxes Paid 0.787 0.448 0.381 0.139 0.013
    Changes in Working Capital -21.375 4.677 59.176 4.295 0.281
    Cash From Investing Activities 90.023 -16.812 -381.721 -53.855 11.194
    Capital Expenditures -8.014 -7.167 -2.538 -1.836 -5.259
    Other Investing Cash Flow Items, Total 98.037 -9.645 -379.183 -52.019 16.453
    Cash From Financing Activities 2.11 7.952 541.274 28.684 80.273
    Issuance (Retirement) of Stock, Net 2.11 7.927 541.274 30.442 80.273
    Net Change in Cash -27.55 -79.529 176.31 -51.23 67.756
    Financing Cash Flow Items 0 0.025 0 -1.758
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 129.136 -149.189 -121.981 -82.125 -34.44
    Cash From Operating Activities -31.094 -119.683 -94.741 -64.378 -39.711
    Cash From Operating Activities 1.76 4.344 3.202 2.095 0.969
    Non-Cash Items -173.143 46.537 36.307 31.31 16.798
    Cash Taxes Paid 0.086 0.787 0.462 0.171 0.037
    Changes in Working Capital 11.153 -21.375 -12.269 -15.658 -23.038
    Cash From Investing Activities 172.202 90.023 78.466 70.626 36.304
    Capital Expenditures -3.58 -8.014 -6.668 -3.67 -1.696
    Other Investing Cash Flow Items, Total 175.782 98.037 85.134 74.296 38
    Cash From Financing Activities 0.867 2.11 1.628 1.304 0.908
    Issuance (Retirement) of Stock, Net 0.867 2.11 1.628 1.304 0.908
    Net Change in Cash 141.975 -27.55 -14.647 7.552 -2.499
    Financing Cash Flow Items 0 0 0

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Schrödinger, Inc. Company profile

    Schrödinger (SDGR) is a computational platform that facilitates the discovery of molecules for drug development and materials design for biopharmaceutical, academic institutions and government laboratories. 

    Founded in 1990, Schrödinger is headquartered in New York. The company has customers and collaborators across more than 70 countries. Its collaborators include Agios Therapeutics, Ajax Therapeutics, Bright Angel Therapeutics, Eli Lilly and Company and Sanofi. 

    Schrödinger specialises in oncology, antifungal, fibrosis, inflammatory bowel diseases, metabolic diseases, cardiopulmonary diseases, tuberculosis, neurodegenerative disease and more. 

    MALT1 inhibitor is a key regulator of physiological antigen receptor signalling in B cells and T cells and are additive to covalent and non-covalent BTK inhibitors. The company announced US Food and Drug Administration (FDA) clearance of an investigational new drug application for SGR-1505, a MALT1 Inhibitor. 

    Schrödinger leverages the software platform to advance its collaborative programmes and its novel therapeutics pipeline includes eight compounds that address unmet medical needs and are currently in the clinical development phase.

    Schrödinger, Inc. stock began trading on the NASDAQ in 2020 under the ticker symbol SDGR. 

    You can track live SDGR share value and price history at Capital.com.

    Industry: Software (NEC)

    1540 Broadway
    24th Floor
    NEW YORK
    NEW YORK 10036
    US

    Income Statement

    • Annual
    • Quarterly

    News

    How to Trade The Triple Top

    Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

    14:13, 27 September 2023
    USA flag on the background of stock charts. Financial system in USA

    Q4 lookahead: US indices starting to show signs of trouble?

    US indices start to draw attention as traders focus on the outlook for Q4.

    07:20, 27 September 2023

    USD/JPY Climbs Towards Key Highs

    USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

    11:32, 26 September 2023

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    People also watch

    Oil - Crude

    88.33 Price
    +0.500% 1D Chg, %
    Long position overnight fee 0.0506%
    Short position overnight fee -0.0725%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    BTC/USD

    27,454.50 Price
    -1.550% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    XRP/USD

    0.54 Price
    +3.860% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    Gold

    1,821.24 Price
    -0.370% 1D Chg, %
    Long position overnight fee -0.0194%
    Short position overnight fee 0.0112%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading